SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Single dose of the antivascular agent, ZD6126 (N-acetylcoichinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model

McIntyre, DJ; Robinson, SP; Howe, FA; Griffiths, JR; Ryan, AJ; Blakey, DC; Peers, IS; Waterton, JC (2004) Single dose of the antivascular agent, ZD6126 (N-acetylcoichinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model. NEOPLASIA, 6 (2). 150 - 157 (8). ISSN 1522-8002 https://doi.org/10.1593/neo.03247
SGUL Authors: Howe, Franklyn Arron

Full text not available from this repository.

Item Type: Article
Additional Information: PubMed ID: 15140404
Keywords: Animals, Disease Models, Animal, Magnetic Resonance Imaging, Necrosis, Neovascularization, Pathologic, Organophosphorus Compounds, Pituitary Neoplasms, Prolactinoma, Rats, Rats, Inbred WF, Regional Blood Flow, Science & Technology, Life Sciences & Biomedicine, Oncology, ZD6126, vascular targeting, therapy, cancer, MRI, VASCULAR-TARGETING AGENT, BLOOD-FLOW, THERAPY, GROWTH, ZD6126, vascular targeting, therapy, cancer, MRI
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Neuroscience (INCCNS)
Journal or Publication Title: NEOPLASIA
ISSN: 1522-8002
Related URLs:
Dates:
DateEvent
1 March 2004Published
Web of Science ID: WOS:000221133400007
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: http://openaccess.sgul.ac.uk/id/eprint/146
Publisher's version: https://doi.org/10.1593/neo.03247

Actions (login required)

Edit Item Edit Item